An anti-HIV peptide T22 is confirmed to be a selective CXCR4/fusin inhibitor by comparative inhibition study of a chemokine SDF-1, synthesized by regioselective disulfide bond formation

Tamamura, H., Matsumoto, F., Sakano, K., Otaka, A., Murakami, T., Nakashima, H., … Fujii, N. (2006). An anti-HIV peptide T22 is confirmed to be a selective CXCR4/fusin inhibitor by comparative inhibition study of a chemokine SDF-1, synthesized by regioselective disulfide bond formation. In Peptide Science — Present and Future (pp. 398–402). Kluwer Academic Publishers. https://doi.org/10.1007/0-306-46864-6_131